Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uveitis.

Santiago Muñoz-Fernández1, Emilio Martín-Mola

  • 1Servicio de Reumatología, Hospital Universitario La Pas, Madrid, Spain. smunoz.hulp@salud.madrid.org

Best Practice & Research. Clinical Rheumatology
|June 17, 2006
PubMed
Summary

Uveitis, an eye inflammation common in young adults, can cause vision loss. Early diagnosis and collaboration between eye and rheumatology specialists improve patient outcomes and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial.

Annals of the rheumatic diseases·2026
Same author

Prevalence of Psoriatic Arthritis in Patients with Moderate-to-Severe Psoriasis in the Era of Biologics and Small Molecule Therapies.

Journal of clinical medicine·2025
Same author

Choroidal thickness as a biomarker of systemic inflammation in patients with polymyalgia rheumatica.

Frontiers in medicine·2025
Same author

Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational study.

Rheumatology (Oxford, England)·2025
Same author

Perception of COVID-19 vaccines in rheumatology patients.

Medicine·2025
Same author

Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors.

Pharmaceuticals (Basel, Switzerland)·2025

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Immunology

Background:

  • Uveitis is a significant cause of visual impairment, particularly in young individuals.
  • Acute anterior uveitis (AAU) is the most common type and frequently linked to spondyloarthropathies.
  • Specific uveitis patterns often indicate underlying systemic conditions, necessitating interdisciplinary care.

Purpose of the Study:

  • To highlight the association between uveitis and systemic diseases.
  • To emphasize the importance of ophthalmologist-rheumatologist collaboration for accurate diagnosis and management.
  • To discuss prognostic factors and therapeutic strategies for different uveitis types.

Main Methods:

  • Review of clinical associations between uveitis and systemic inflammatory conditions.
  • Analysis of prognostic indicators for various uveitis presentations.
  • Evaluation of treatment outcomes for medications like sulphasalazine and infliximab.

Main Results:

  • Acute anterior uveitis generally has a better prognosis than other forms, but frequent flares can lead to disability.
  • Sulphasalazine has shown potential in reducing flare frequency in small studies.
  • More severe uveitis forms often require systemic corticosteroids or immunosuppressants.
  • Infliximab presents a viable treatment option for specific patient groups.

Conclusions:

  • Close collaboration between ophthalmologists and rheumatologists is crucial for effective uveitis management.
  • Tailored treatment strategies, including newer biologics like infliximab, are essential for managing complex uveitis cases.
  • Understanding uveitis patterns aids in identifying associated systemic diseases and guiding therapy.

Related Experiment Videos